LEONARDA-2: Lerociclib plus letrozole versus placebo plus letrozole in HR+/HER2- advanced or metastatic breast cancer.Xichun Hu, Biyun Wang, Shusen Wang et al.|Journal of Clinical Oncology|2024Cited by 1